Pazopanib

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

37 Suppliers, 13 USDMF, 6 EU WC, 5 KDMF, 9 NDC API, 33 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

35 Suppliers

35 Suppliers

DOSSIERs // Finished Dosage Forms

23 Dossiers, 5 FDA Orange Book, 2 Europe, 1 Canada, 15 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 15 Kerry, 12 Seppic, 11 Roquette, 10 Corel Pharma Chem, 10 BASF, 9 Gangwal Chemicals, 9 Sigachi Industries, 9 Microlex e.U, 6 Gangwal Healthcare, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Kima Chemical, 3 Prachin Chemical, 3 Vasa Pharmachem, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Pharmatrans-Sanaq, 3 DFE Pharma, 2 Nanjing Well Pharmaceutical, 2 The Dow Chemical Company, 2 Actylis, 1 Clariant, 1 Nanjing Bold Chemical, 1 Ingredion Pharma Solutions, 1 Jai Radhe Sales, 1 SPI Pharma, 1 ACG Worldwide, 1 Qualicaps, 1 Ulanqab Kema New Material, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Boai NKY Pharmaceuticals Ltd

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 28 Fillers, Diluents & Binders, 23 Controlled & Modified Release, 18 Disintegrants & Superdisintegrants, 18 Solubilizers, 17 Direct Compression, 14 Thickeners and Stabilizers, 13 Granulation, 11 Lubricants & Glidants, 10 Film Formers & Plasticizers, 8 Parenteral, 7 Co-Processed Excipients, 5 Empty Capsules, 5 Emulsifying Agents, 5 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 3 Chewable & Orodispersible Aids, 2 Coloring Agents

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

8 US Medicaid Prescriptions

MARKET PLACE

2 APIs, 5 DOSSIERS // FDF

PATENTS

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods

1 BioAnalytical Methods

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 12 News

Information, Expiry & Status of Health Canada Patents covering Pazopanib.

Pazopanib

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

37 Suppliers

13 USDMF

6 EU WC

5 KDMF

9 NDC API

33 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

35 Suppliers

DOSSIERs // Finished Dosage Forms

23 Dossiers

5 FDA Orange Book

2 Europe

1 Canada

15 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 200MG BASE

TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

15 Kerry

12 Seppic

11 Roquette

10 Corel Pharma Chem

10 BASF

9 Gangwal Chemicals

9 Sigachi Industries

9 Microlex e.U

6 Gangwal Healthcare

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Kima Chemical

3 Prachin Chemical

3 Vasa Pharmachem

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Pharmatrans-Sanaq

3 DFE Pharma

2 Nanjing Well Pharmaceutical

2 The Dow Chemical Company

2 Actylis

1 Clariant

1 Nanjing Bold Chemical

1 Ingredion Pharma Solutions

1 Jai Radhe Sales

1 SPI Pharma

1 ACG Worldwide

1 Qualicaps

1 Ulanqab Kema New Material

1 Qianhao Chemical (Hebei) Co., Ltd

1 Boai NKY Pharmaceuticals Ltd

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives

28 Fillers, Diluents & Binders

23 Controlled & Modified Release

18 Disintegrants & Superdisintegrants

18 Solubilizers

17 Direct Compression

14 Thickeners and Stabilizers

13 Granulation

11 Lubricants & Glidants

10 Film Formers & Plasticizers

8 Parenteral

7 Co-Processed Excipients

5 Empty Capsules

5 Emulsifying Agents

5 Topical

4 Vegetarian Capsules

4 API Stability Enhancers

TABLET;ORAL - EQ 400MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons